Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC), a severe and fast-growing type of bladder cancer that penetrates the thick muscle layer of the bladder wall. After ...
Surgery hasn’t always been an option for metastatic bladder cancer (or bladder cancer that’s spread from its original site). But according to limited research, surgical treatments may now help some ...
Speculation swirled for weeks around the health of Deion Sanders, Colorado Buffaloes head coach and famed Pro Football Hall of Fame inductee, who had been notably absent from team practice. When he ...
FDA authorization extends perioperative pembrolizumab plus enfortumab vedotin to cystectomy-eligible muscle-invasive bladder cancer, removing the prior restriction to cisplatin-ineligible patients.
Novo Nordisk and Eli Lilly say GLP-1 drugs slowed aging clocks, but the data are early and unreviewed. Here is what patients should know. Had Gestational Diabetes or Postpartum Depression? Large Study ...
Can growing blood vessels within a lab-engineered graft improve bladder reconstruction for children? For more than two decades, UC Davis pediatric urologic surgeon Eric Kurzrock has been developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results